The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...

NeoGenomics’ third quarter results were met with a negative market reaction, as shares declined following the announcement. Management attributed the quarter’s performance to robust growth in clinical ...

MiDOG Animal Diagnostics is proud to announce the appointment of Dr. Curtis Huttenhower, PhD, Dr. Micah B. Kohles, DVM, MPA, and Dr. Krista A. Keller, DVM, Dipl. ACZM to its Board of Directors and ...

GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 7th Annual Wolfe Research Healthcare ...

“These results are encouraging, highlighting TET2-mutated clonal hematopoiesis as a potential biomarker to select patients ...

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the third quarter 2025 following ...

Twist Bioscience is advancing synthetic DNA manufacturing with innovation but remains at the lower end of its 52-week range.

Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., ...

The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...

SportsLine college football expert Bruce Marshall, the longtime executive editor of The Gold Sheet, has gathered information ...